Approved for use
through 7/2005 under the condition that prior to fielding this
instrument, CMS submits to OMB a plan for: 1) tracking response
rates for the drug utilization and cost questions, 2) comparing
these data to similar information from surveys such as the MEPS and
MCBS; 3) sharing this information with OMB as soon as it is
available during the survey effort. In addition,OMB appreciates the
thorough justification for the use of payment incentives in this
effort, but emphasizes that acceptance of incentives in this case
should not be perceived as a precedent for future PRA submissions.
OMB will continue to evaluate the use of incentives on a
case-by-case basis.
Inventory as of this Action
Requested
Previously Approved
07/31/2005
07/31/2005
1,680
0
0
1,106
0
0
0
0
0
This demonstration will focus on two
Medicare sponsored, lifestyle modification programs designed to
reverse, reduce or ameliorate the progression of coronary artery
disease (CAD) at risk for significant morbidity and mortality. This
demonstration will test the cost-effectiveness and feasibility of
providing payment for cardiovascular lifestyle modification program
services to Medicare beneficiaries.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.